전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-2 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,047 programs
AntibodyLimited DatastaleXin-Hua XuPhase 2

Sindillimab (Sindillimab)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#monoclonal-antibody#Xin-Hua
Trials 1Status Active
AntibodyLimited DatastaleInnoventPhase 2

PD-1 inhibitor (Sintilimab, Sintilimab (PD-1 inhibitor))

Large B Cell Diffuse Lymphoma; Mantle Cell Lymphoma (MCL) · PD-1

#PD-1#Antibody#Phase2#monoclonal-antibody#LargeBCellDiffuseLymphoma+2
Trials 1Status Recruiting
AntibodyLimited DatastaleInnoventPhase 2

Sintilimab and Bevacizumab Combined with Radiotherapy (Sintilimab and Bevacizumab Combined with Radiotherapy)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#Innovent
Trials 1Status Active
AntibodyLimited DatastaleInnoventPreclinical

Sintilimab combined with Bevacizumab (Sintilimab combined with Bevacizumab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Preclinical#monoclonal-antibody#Innovent
Trials 1Status Active
AntibodyLimited DatastaleInnoventPreclinical

pembrolizumab (Keytruda, MPA, Sintilimab or Pembrolizumab and medroxyprogesterone acetate, Sintilimab or Pembrolizumab and medroxyprogesterone acetate (MPA)/ megestrol acetate (MA))

Endometrial Cancer; Endometrioid Carcinoma · Endometrial Cancer

#EndometrialCancer#Antibody#Preclinical#monoclonal-antibody#EndometrioidCarcinoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleNational Cancer Institute (NCI)Phase 1

Siplizumab (Siplizumab)

T-Cell Peripheral Lymphoma; Gamma Delta Hepatosplenic T-Cell Lymphoma · T-Cell Peripheral Lymphoma

#T-CellPeripheralLymphoma#Antibody#Phase1#monoclonal-antibody#GammaDeltaHepatosplenicT-CellLym+1
Trials 1Status Active
AntibodyLimited DatastaleNewcastle UniversityApproved

Solu-medrone, Mabthera (Solu-medrone, Mabthera)

Autoimmune Adrenocortical Failure · Autoimmune Adrenocortical Failure

#AutoimmuneAdrenocorticalFailure#Antibody#Approved#monoclonal-antibody#Newcastle
Trials 1Status Active
AntibodyLimited DatastaleMoonLake Immunotherapeutics AGPhase 2

Sonelokimab (Sonelokimab)

Arthritis, Psoriatic · Arthritis, Psoriatic

#ArthritisPsoriatic#Antibody#Phase2#monoclonal-antibody#Arthritis+2
Trials 1Status Active
AntibodyLimited DatastaleMoonLake Immunotherapeutics AGPhase 2

M1095 (Sonelokimab, Sonelokimab (M1095))

Hidradenitis Suppurativa · Hidradenitis Suppurativa

#HidradenitisSuppurativa#Antibody#Phase2#monoclonal-antibody#MoonLake
Trials 1Status Active
AntibodyLimited DatastaleUniversity of OxfordPhase 2

Sotrovimab (Sotrovimab)

COVID-19 · COVID-19

#COVID-19#Antibody#Phase2#monoclonal-antibody#University
Trials 1Status Recruiting
AntibodyLimited DatastaleM.D. Anderson Cancer CenterPhase 2

Standard Dose Bevacizumab (Standard Dose Bevacizumab)

Brain Cancer; Glioblastoma · Brain Cancer

#BrainCancer#Antibody#Phase2#monoclonal-antibody#Glioblastoma+1
Trials 1Status Active
AntibodyLimited DatastaleAmsterdam UMC, location VUmcPhase 2

Standard dose cetuximab (Standard dose cetuximab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#monoclonal-antibody#Amsterdam
Trials 1Status Discontinued
AntibodyLimited DatastaleAsan Medical CenterApproved

Standard infliximab intravenous therapy (Standard infliximab intravenous therapy)

Crohn Disease; Infliximab · Crohn Disease

#CrohnDisease#Antibody#Approved#monoclonal-antibody#Infliximab+1
Trials 1Status Recruiting
AntibodyLimited DatastaleOslo University HospitalPhase 3

daratumumab (Darzalex, Standard treatment of relapse with carfilzomib, dexamethasone, daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#monoclonal-antibody#Oslo
Trials 1Status Recruiting
AntibodyLimited DatastaleAbbVieApproved

adalimumab (Humira, Standard-Dose Adalimumab)

Crohn Disease (CD) · Crohn Disease (CD)

#CrohnDiseaseCD#Antibody#Approved#monoclonal-antibody#AbbVie
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenApproved

Standard-Dose infliximab (Standard-Dose infliximab)

Crohn Disease (CD) · Crohn Disease (CD)

#CrohnDiseaseCD#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Recruiting
AntibodyLimited DatastaleAbbVieApproved

adalimumab (Humira, Start adalimumab in monotherapy)

CD · CD

#CD#Antibody#Approved#monoclonal-antibody#AbbVie
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

Steroid + rituximab (Steroid + rituximab)

Acquired Haemophilia · Acquired Haemophilia

#AcquiredHaemophilia#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleSanofiApproved

Stopping dupilumab (Stopping dupilumab)

Severe Asthma · Severe Asthma

#SevereAsthma#Antibody#Approved#monoclonal-antibody#Sanofi
Trials 1Status Recruiting
AntibodyLimited DatastaleRocheApproved

Subconjunctival Bevacizumab (Subconjunctival Bevacizumab)

Glaucoma · Glaucoma

#Glaucoma#Antibody#Approved#monoclonal-antibody#Roche
Trials 1Status Active

86 / 103 pages

← PreviousNext →